B. Kahan

发表

B. Kahan, B. Kahan, 2004, Transplantation proceedings.

Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.

S. Gruber, B. Susskind, C. V. van Buren, 1999, Transplantation.

Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.

S. Stepkowski, B. Kahan, P. Daloze, 1991, Transplantation.

Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.

S. Stepkowski, B. Kahan, Mou-Er Wang, 1998, Therapeutic drug monitoring.

PROSPECTIVE, RANDOMIZED TRIAL OF THE EFFECT OF ANTIBODY INDUCTION IN SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION: THREE-YEAR RESULTS1

M. Stegall, A. Henning, A. Gaber, 2004, Transplantation.

FTY 720 prevents ischemic reperfusion damage in rat kidneys.

B. Kahan, P. Troncoso, M. Ortiz, 2001, Transplantation proceedings.

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group.

B. Julian, M. Pescovitz, Y. Vanrenterghem, 1999, Transplantation.

Low intraindividual variability of cyclosporin A exposure reduces chronic rejection incidence and health care costs.

D. Urbauer, K. Beusterien, C. V. van Buren, 2000, Journal of the American Society of Nephrology : JASN.

Sirolimus: a ten-year perspective.

B. Kahan, B. Kahan, 2004, Transplantation proceedings.

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation.

H. Meier‐Kriesche, C. V. van Buren, J. Podbielski, 1999, Transplantation.

Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.

C. V. van Buren, B. Kahan, Z. Káposztás, 2009, Transplantation proceedings.

Campath-1H as rescue therapy for the treatment of acute rejection in kidney transplant patients.

H. Podder, V. Pollard, B. Kahan, 2005, Transplantation proceedings.

Induction of specific allograft immunity by soluble class I MHC heavy chain protein produced in a baculovirus expression system.

S. Stepkowski, G. He, B. Kahan, 1996, Transplantation.

Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients.

P. Kimball, C. V. van Buren, R. Kerman, 1991, Transplantation.

Comparison of Sirolimus Plus Tacrolimus Versus Sirolimus Plus Cyclosporine in High-Risk Renal Allograft Recipients: Results From an Open-Label, Randomized Trial

C. V. van Buren, J. Neylan, J. Scarola, 2008, Transplantation.

Role of therapeutic drug monitoring of rapamycin.

B. Kahan, K. Napoli, B. Kahan, 1998, Transplantation proceedings.

Sirolimus improves the two-year outcome of renal allografts in African-American patients

C. V. van Buren, J. Podbielski, B. Kahan, 2001, Transplant international : official journal of the European Society for Organ Transplantation.

Cyclosporin A tissue levels in a cadaveric renal allograft recipient.

M. Boileau, S. Flechner, W. Payne, 1983, Transplantation.

Comparing an Early Corticosteroid/Late Calcineurin-Free Immunosuppression Protocol to a Sirolimus-, Cyclosporine A-, and Prednisone-Based Regimen for Pancreas-Kidney Transplantation

C. V. van Buren, R. Kerman, H. Podder, 2010, Transplantation.

Selective corticosteroid and calcineurin‐inhibitor withdrawal after pancreas–kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy

H. Podder, E. McKissick, C. Buren, 2008, Clinical Transplantation.

A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.

C. V. van Buren, R. Kerman, B. Kahan, 2005, Transplantation proceedings.

Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.

C. V. van Buren, R. Kerman, B. Kahan, 1990, Transplantation.

Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat.

R. Schreiber, R. Didlake, B. Kahan, 1988, Transplantation.

Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.

S. Chueh, S. Stepkowski, B. Kahan, 1997, Transplantation.

Effect of sirolimus on the metabolism of apoB100- containing lipoproteins in renal transplant patients.

C. Ballantyne, H. Pownall, A. Opekun, 2001, Transplantation.

The influence on pretransplant blood transfusions from random donors on immune parameters affecting cadaveric allograft survival.

G. Agostino, S. Flechner, W. Payne, 1983, Transplantation.

The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients.

B. Radovancević, O. Frazier, B. Susskind, 1998, Transplantation.